BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 20131268)

  • 1. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Puéchal X; Carli P; Kyndt X; Le Hello C; Letellier P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2010 Apr; 62(4):1186-97. PubMed ID: 20131268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.
    Guillevin L; Cohen P; Mahr A; Arène JP; Mouthon L; Puéchal X; Pertuiset E; Gilson B; Hamidou M; Lanoux P; Bruet A; Ruivard M; Vanhille P; Cordier JF
    Arthritis Rheum; 2003 Feb; 49(1):93-100. PubMed ID: 12579599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
    Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
    Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years.
    Guillevin L; Lhote F; Jarrousse B; Fain O
    Ann Med Interne (Paris); 1992; 143(6):405-16. PubMed ID: 1363508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classical polyarteritis nodosa and microscopic polyangiitis--a clinicopathologic study.
    Handa R; Wali JP; Gupta SD; Dinda AK; Aggarwal P; Wig N; Biswas A
    J Assoc Physicians India; 2001 Mar; 49():314-9. PubMed ID: 11291968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.
    Pagnoux C; Quéméneur T; Ninet J; Diot E; Kyndt X; de Wazières B; Reny JL; Puéchal X; le Berruyer PY; Lidove O; Vanhille P; Godmer P; Fain O; Blockmans D; Bienvenu B; Rollot F; Aït el Ghaz-Poignant S; Mahr A; Cohen P; Mouthon L; Perrodeau E; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2015 Apr; 67(4):1117-27. PubMed ID: 25693055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
    N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.
    Guillevin L; Jarrousse B; Lok C; Lhote F; Jais JP; Le Thi Huong Du D; Bussel A
    J Rheumatol; 1991 Apr; 18(4):567-74. PubMed ID: 1676753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
    Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.
    Samson M; Puéchal X; Mouthon L; Devilliers H; Cohen P; Bienvenu B; Ly KH; Bruet A; Gilson B; Ruivard M; Pertuiset E; Hamidou M; Pagnoux C; Terrier B; Guillevin L;
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):176-184. PubMed ID: 28422001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.
    Samson M; Puéchal X; Devilliers H; Ribi C; Cohen P; Bienvenu B; Ruivard M; Terrier B; Pagnoux C; Mouthon L; Guillevin L;
    Autoimmun Rev; 2014 Feb; 13(2):197-205. PubMed ID: 24161361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapses in patients with a systemic vasculitis.
    Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Howie AJ; Bacon PA
    Q J Med; 1993 Dec; 86(12):779-89. PubMed ID: 7906421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide therapy of severe systemic necrotizing vasculitis.
    Fauci AS; Katz P; Haynes BF; Wolff SM
    N Engl J Med; 1979 Aug; 301(5):235-8. PubMed ID: 36563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors.
    Samson M; Puéchal X; Devilliers H; Ribi C; Cohen P; Bienvenu B; Terrier B; Pagnoux C; Mouthon L; Guillevin L;
    Autoimmun Rev; 2014 Sep; 13(9):945-53. PubMed ID: 25153486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
    Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
    Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.